The determination of ADME, toxicity, drug-likeness parameters, and anticancer activity of cis-[Pt(Oro)(NH3)2]      
Yazarlar (4)
Doç. Dr. Çiğdem BİLKAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ceren Kocaman
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Meriç Arda Eşmekaya
Gazi Üniversitesi, Türkiye
Prof. Dr. Mustafa Tuğfan BİLKAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Computational and Theoretical Chemistry
Dergi ISSN 2210-271X Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili Türkçe
Basım Tarihi 08-2024
Cilt No 1238
Sayı 1
DOI Numarası 10.1016/j.comptc.2024.114752
Makale Linki http://dx.doi.org/10.1016/j.comptc.2024.114752
Özet
In this study, it was aimed to obtain the anticancer potential, pharmacokinetic and toxicity profiles of the cis-[Pt(oro)(NH3)2]. The structural parameters of the compound were determined. The effects of solvent environments were also investigated on the molecule because they are an important factor that should be taken into account in drug research processes. Pharmacokinetic and toxicity parameters of the molecule were obtained by using in silico predictions, which are good preliminary for in vitro and in vivo studies. The drug absorption, distribution, metabolism, and excretion parameters of cis-[Pt(oro)(NH3)2] were compared with those of the anticancer drug cisplatin. Molecular docking studies on oncogenes were conducted to define the anticancer potential of the molecule. The obtained ADME results showed that the title molecule's toxicity is significantly lower than cisplatin. Molecular docking studies have revealed that the molecule docks well with the oncogene and thus may be a promising potential anticancer agent.
Anahtar Kelimeler
Cancer research | In silico predictions | Molecular docking | Platinum complexes